0000899243-20-014729.txt : 20200601 0000899243-20-014729.hdr.sgml : 20200601 20200601163146 ACCESSION NUMBER: 0000899243-20-014729 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200528 FILED AS OF DATE: 20200601 DATE AS OF CHANGE: 20200601 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PATRICK DEVAL L CENTRAL INDEX KEY: 0001053466 STANDARD INDUSTRIAL CLASSIFICATION: AIR TRANSPORTATION, SCHEDULED [4512] STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37539 FILM NUMBER: 20933770 MAIL ADDRESS: STREET 1: BAIN CAPITAL, LLC STREET 2: 200 CLARENDON STREET CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Global Blood Therapeutics, Inc. CENTRAL INDEX KEY: 0001629137 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 274825712 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 181 OYSTER POINT BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650741-7700 MAIL ADDRESS: STREET 1: 181 OYSTER POINT BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-05-28 0 0001629137 Global Blood Therapeutics, Inc. GBT 0001053466 PATRICK DEVAL L C/O GLOBAL BLOOD THERAPEUTICS, INC. 181 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Stock Option (Right to Buy) 68.75 2020-05-28 4 A 0 625 0.00 A 2030-05-27 Common Stock 625 625 D Restricted Stock Units 2020-05-28 4 A 0 2400 0.00 A Common Stock 2400 2400 D The shares subject to this option shall vest and become exercisable in a single installment on June 28, 2020, subject to the Reporting Person's continued service on the Issuer's Board of Directors. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The shares of Common Stock underlying the RSUs vest in a single installment on June 28, 2020, subject to the Reporting Person's continued service on the Issuer's Board of Directors. /s/ Tricia Suvari, as Attorney-in-Fact 2020-06-01